 |
| Pennsylvania Bio Member Companies Respond to Hurricane Katrina Victims |
Donations, medications, and other products and services being sent
By Fritz Bittenbender
President
Pennsylvania Bio
Last week, one of the worst natural disasters ever to hit the United States slammed into the Gulf Coast. The extent of the devastation is still to be determined, and the next months and years will show the determination and strength of the people of Louisiana, Mississippi, and Alabama. But the immediate needs could overwhelm anyone. Fortunately, the United States is the strongest, most giving nation in the world, and that is being shown in the response by all Americans to the devastation wrought by Hurricane Katrina.
Pennsylvania Bio is proud of its member companies’ responses to this disaster, and I would like to take this space to thank all of them, and all of our members that are encouraging employees to aid the victims of Katrina. The bio-pharmaceutical industry globally is one of the most giving industries. Read more about Pennsylvania Bio Members' Responses >> |
|
|
|
FEATURE ARTICLE
Pennsylvania Bio and Life Science Analytics Launch Pennsylvania Bio MedTRACK
Pennsylvania Bio has teamed with Life Science Analytics to launch a new database on the Pennsylvania Bio website—Pennsylvania Bio MedTRACK.
For Pennsylvania Bio members, media and legislators, Pennsylvania Bio MedTRACK provides a wealth of information on the bioscience community in Pennsylvania. The database allows users to search for company information, product information, pipelines, and more. The search capabilities of Pennsylvania Bio MedTRACK allow users to choose a disease category and subcategory to research Pennsylvania Bio companies working in that area. Also available are business descriptions, product summaries, product details, recent financings, corporate partners. Additionally, users can search for companies by geography, including county, city, or zip code.
Pennsylvania Bio members: click here to request your login information.
For information about joining Pennsylvania Bio, click here.
Click for additional information >> |
|
|
|
Inside The Industry
|
| Cephalon Files New Drug Application for OraVescent(R) Fentanyl for the Management of Breakthrough Pain in Cancer Patients
-
Read the full article |
|
Wyeth's New Drug Application for New Oral Contraceptive with Uninterrupted Dosing Regimen Accepted For Filing At FDA
− Clinical Trials Evaluated Safety and Efficacy Data for Contraception as Well as Menses Inhibition −
-
Read the full article |
|
|
|
| Targepeutics, Inc. Announces Patent License Agreement With National Institutes of health (NIH)
-
Read the full article |
|
|
TheraQuest Biosciences, LLC. Receives 7-Year Market Exclusivity for Neuropathic Pain Indication for Abuse Deterrent, Once-Daily Tramadol
-
Read the full article |
|
| Cellumen and RheoGene Sign Licensing and Collaboration Agreement for Systems Cell Biology Profiling Reagents for High Content Screening
-
Read the full article |
|
|
Regional News
|
FEATURE ARTICLE
Greenhouse Update
BioAdvance is Accepting Registrations for Greenhouse Funding
BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, is accepting registrations for the Greenhouse Fund’s current investment cycle for early stage life science enterprises. Registrants may go online at www.bioadvance.com to complete the form and review the application instructions and related information. The application deadline is September 30th for the current funding cycle. For any additional information regarding the registration form or the application process please contact BioAdvance at application@bioadvance.com.
Pittsburgh Life Sciences Greenhouse seeks $150M fund
The Pittsburgh Life Sciences Greenhouse is looking to raise a $150 million venture fund, as part of its plan to jump-start growth in the local biotech community.
Read the full article >> |
| GlaxoSmithKline Acquires Vaccine R&D And Manufacturing Plant In The US; 270 New Jobs to be Created
-
Read the full article |
|
| Sanofi Pasteur to Increase U.S. Influenza Vaccine Capacity with Construction of New Plant
-
Read the full article |
|
|
|
|
Funding Focus
|
| Protez Pharmaceuticals, Inc. Closes $15 Million Financing To Progress Lead Antibiotic Compound
-
Read the full article |
|
Penn State Hershey Medical Center research funding tops $100 million
− Research funding total highest ever in the Medical Center's history −
-
Read the full article |
|
Hillman Contributes $20 Million to the University of Pittsburgh Cancer Institute and UPMC Cancer Centers
− Largest single gift ever given to UPMC and University of Pittsburgh part of $200 million initiative−
-
Read the full article |
|
|
Government Watch
|
FEATURE ARTICLE
Profiled Legislator
State Senator Rob Wonderling, R-24th
Senator Rob Wonderling was elected to his first term in the Pennsylvania Senate in November 2002. Senator Wonderling is currently chairman of the Communications and Technology Committee, and he is a member of the Aging and Youth, Consumer Protection & Professional Licensure, Finance, and Local Government Committees.
Senator Wonderling represents the 24th district which includes parts of Bucks, Lehigh, Montgomery, and Northampton Counties. His district is home to companies such as Entopath, MB Research Laboratories, Membrane Assays and others.
Read the full article >> |
|
|
|
|
|
|
|
Profiled Member
|
 Locus Pharmaceuticals
www.locuspharma.com
Locus Pharmaceuticals, Inc. is a world leader in computational drug design. Since beginning operations in 2000, Locus has developed and evolved unique and potentially transformational capabilities for the in silico design and optimization of small molecule drugs. These proprietary computational approaches are combined with in-house expertise in chemistry, biology and crystallography to create a fully integrated drug discovery platform. Locus believes that its capabilities offer the potential to substantially lower the cost of drug discovery and greatly increase the speed of advancing novel therapies to clinical trials and, ultimately, to the market.
-
Read more about Locus Pharmaceuticals |
|
|
Job Watch
|
Are you exploring your next career opportunity in the biosciences or looking for talent for your company? Pennsylvania Bio has partnered with Adsumo to create a resource to assist our members in finding qualified candidates and helping the job seeker in their search for rewarding opportunities in the biosciences.
For more details, contact Ian King of Adsumo at 215.922.0260 ext. 3038, iking@adsumo.com, or Lisa Goldsborough of Pennsylvania Bio at 610.578.9220, lisa@pennsylvaniabio.org.
-
Read the full article |
|
|
Events
|
2005 BIO LIFE TECH Venture Conference
September 13 – 14, 2005
Hyatt Regency Baltimore
Baltimore, MD
Applications are now being accepted for the 2005 BIO LIFE TECH Venture Conference.
BIO LIFE TECH is the trendsetter in showcasing the most promising young companies in the biotechnology, nanotechnology, life sciences, and pharmaceutical industries. Companies that would like to participate in BIO LIFE TECH 2005 are invited to apply at Bio Life Tech. The deadline to apply is August 5. |
|
BioBlast - "The Common Ground for Science & Business"
September 22, 2005
Bridgeside POint, Cellomics Building
Pittsburgh, PA
Come to BioBlast, and interact with fellow life scientists. Over drinks and food, share tidbits about research, start-ups, and discoveries. Meet venture capitalists, entrepreneurs, scientists, and business people from the life sciences industry.
For more information: BioBlast
|
|
Cross Over 2005: Exploring the interface of the life sciences and materials at Penn State University
October 13 & 14, 2005
University Park, PA
The program includes invited government agency speakers, invited PSU and Hershey Faculty, and selected industry speakers. These presentations will be complemented by more than 70 selective poster presentations by PSU and Hershey faculty research groups.
For additional information or to register, visit: Cross Over 2005
|
|
Mid Atlantic Venture Conference
October 17 & 18, 2005
Philadelphia Convention Center
Philadelphia, PA
This one-and-a-half day event, held at the Pennsylvania Convention Center in Philadelphia, showcases the best young companies in the Mid-Atlantic region and provides these companies with incomparable exposure to the region's top VCs and private equity investors.
For additional information, please visit Mid Atlantic Venture Conference. |
|
IBC’s Translational Medicine
Activities to Enable Early Clinical Development
October 24-25, 2005
Philadelphia, PA
IBC’s Life Sciences, together with Select Greater Philadelphia, and its distinguished Scientific Advisory Board, has designed a conference devoted to Translational Medicine. This exciting event will be held at The Inn at the Union League on October 24-25, 2005 in Philadelphia, PA.
This program takes a comprehensive look at optimizing the impact of translational medicine activities, and effectively translating them to applicable tactics to enable efficient early clinical development, from the discovery phase, extending through proof of concept. Examine the optimum use of biomarkers and bioimaging technologies as useful predictor models for safety, efficacy and compound behavior to increase the probability for early attrition, and decrease late-phase attrition.
Special Offer for all Pennsylvania Bio members. Register now using code KY3131PB and receive $300 off your registration. Visit www.IBCLifeSciences.com/3131 to register.
More information |
|
|
 |
|
